Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice

History of Atz/Bev treatment may be an independent clinical factor for poor PFS at Dur/Tre introduction.

Authors

Institutions

Publication Details

Journal
Hepatology Research
Published
2024-11-11
DOI
https://doi.org/10.1111/hepr.14136
Citations
11
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
4.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice

Hideko Ohama, Norio Itokawa, Joji Tani, Kazunari Tanaka et al.
11 citations
Hepatology Research
Hepatocellular Carcinoma Treatment and Prognosis
4.06
article

Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice

Hideko Ohama, Norio Itokawa, Joji Tani, Kazunari Tanaka, Yuki Kanayama, Tomomitsu Matono, Hidenao Noritake, Kazuhito Kawata, Kazuya Kariyama, Hironori Ochi, Hidenori Toyoda, Hirayuki Enomoto, Kazuhiro Nouso, Takeshi Hatanaka, Masatoshi Kudo, Yoichi Hiasa, Kunihiko Tsuji, Atsushi Hiraoka, Takashi Kumada, Yoshiko Nakamura, Shinya Fukunishi, Tomomi Okubo, Takuya Nagano, Ei Itobayashi, Masashi Hirooka, Hiroki Nishikawa, Hisashi Kosaka, Kazuto Tajiri, Takashi Nishimura, Toshifumi Tada, Atsushi Naganuma, Akemi Tsutsui, Hidekatsu Kuroda, Toru Ishikawa, Satoru Kakizaki, Yutaka Yata, Masanori Atsukawa, Yuichi Koshiyama, Tomoko Aoki, Fujimasa Tada, Asahiro Morishita, Koichi Takaguchi, Michitaka Imai, Masaki Kaibori, Hironori Tanaka, Taeang Arai, Shinichiro Nakamura, Chikara Ogawa
article en
11 citations

Abstract

History of Atz/Bev treatment may be an independent clinical factor for poor PFS at Dur/Tre introduction.

Hepatology ResearchVol. 55(3)
Kansai Medical University (JP), Iwate Medical University (JP), Kagawa University (JP), Hamamatsu University School of Medicine (JP), Niigata Cancer Center Hospital (JP), Takamatsu Red Cross Hospital (JP), Saiseikai Niigata Daini Hospital (JP), National Hospital Organization Takasaki Medical Center (JP), Matsuyama Red Cross Hospital (JP), Ogaki Municipal Hospital (JP), Himeji Medical Center (JP), Hanwa Memorial Hospital (JP), Gunma Saiseikai Maebashi Hospital (JP), Himeji Red Cross Hospital (JP), Teine Keijinkai Hospital (JP), Asahi General Hospital (JP), Toyama University Hospital (JP), Ehime Prefectural Central Hospital (JP), Kagawa Prefectural Central Hospital (JP), Takarazuka City Hospital (JP), Ehime University (JP), Gifu Kyoritsu University (JP), Nippon Medical School (JP), Hyogo University (JP), Osaka University of Pharmaceutical Sciences (JP), Kindai University (JP)
Good health and well-being
Openalex Percentile: Top 5%
Hepatocellular Carcinoma Treatment and Prognosis
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.